Tweet
2 Ministry of Health informed that, as of February 28, 2010, Of the total confirmed cases of Influenza A H1N1 influenza 127,000 cases, of which 793 cases of death.
通 報指出，2010年2月，全國流感哨點監測結果顯示，醫院共報告流感樣病例19.7萬例，比1月份減少22 .9%，全國流感流行強度與前兩年同期平均水準 基本持平；流感病例佔流感樣病例的比例為24.4%，比2010年1月的29.4%有所下降；甲型H1N1 流感病例佔流感病例的比例為11.1%，比1月 的36.6%明顯下降。
The circular pointed out, in February 2010, the National Influenza sentinel surveillance showed that the hospital reported a total of 197,000 cases of influenza-like illness, decreased by 22.9% compared with January, the National Strength and pandemic influenza the same period in the previous two years average flat; influenza cases accounted for The proportion of influenza-like cases 24.4%, compared with January 2010 decreased 29.4%; Influenza A H1N1 influenza cases accounted for the proportion of influenza cases was 11.1%, 36.6% more than in January decreased significantly. 根據流感監測數據，專家認為我國甲型H1N1流感已度過秋冬流感高峰期，目前處於低發期，病毒監測沒有發現 明顯變異。
Under the influenza surveillance data, influenza A H1N1 influenza experts believe that China has spent the winter peak period of influenza is currently a low-fat period, the virus monitor found no significant variation. 通報指出，2010年2月份我國內地疫情主要有以下特點：
Report pointed out that the Mainland of China in February 2010 the epidemic has the following characteristics: ??病毒基因測序未發現明顯變異。
- Viral gene sequencing found no significant variation. 2月份，國家流感中心共對58株甲型H1N1流感病毒進行測序，未發現耐藥性毒株；病毒毒力、致病力和抗原 性未發生明顯變化。
In February, the National Influenza Center, a total of 58 influenza A H1N1 influenza viruses were sequenced and found no drug-resistant strains; virulence, pathogenicity and antigenicity did not change significantly. ??甲型H1N1流感每週報告新增確診病例數、流感樣病例佔門急診病例的比例、甲型H1N1流感病例佔流感 病例的比例均維持在較低水準，全國暴發疫情明顯減少。
- Influenza A H1N1 influenza weekly report the number of new confirmed cases of influenza-like illness accounted for the proportion of outpatient and emergency cases, influenza A H1N1 influenza cases accounted for the proportion of influenza cases has remained at a relatively low level, the National outbreaks decreased significantly. ??新增重症和死亡病例數降至較低水準。
- Add the number of cases of severe and death to a lower level. 孕婦在重症病例和死亡病例中所佔比例分別為10.5%和19.2%，與1月份的比例基本持平。
Pregnant women and death in severe cases the proportion of cases, respectively 10.5% and 19.2%, and in January the ratio was essentially flat. ??全人群免疫保護水準不斷提高。
- Level of immune protection of the whole population continues to increase. 綜合部分地區人群感染水準調查結果和甲型H1N1流感疫苗接種情況，專家推算，我國內地約30%的人口具有 抵抗甲型H1N1流感病毒感染的免疫保護力。
Integrated parts of the population infected with the standard findings and Influenza H1N1 influenza vaccine situation, experts estimated that the Mainland of China by about 30% of the population are resistant to influenza A H1N1 influenza virus infection in immuno-protection force. 另據通報，截至2月28日，國家食品藥品監督管理局累計受理甲型H1N1流感疫苗簽批發1.5億余人份；全 國累計完成甲流疫苗接種8212萬人。
It was also informed that as at February 28, the State Food and Drug Administration received cumulative wholesale sign Influenza H1N1 influenza vaccine more than 150 million copies; the country to complete a total flow of 82.12 million people vaccinated. 甲型H1N1流感疫苗接種異常反應監測顯示，疑似預防接種異常反應報告發生率約為9.55/10萬，嚴重異常反應報告發生率約為0.1/10萬。
Influenza A H1N1 Influenza vaccination abnormal reaction monitoring shows abnormal reaction to the report of suspected vaccination rate is about 9.55/10 million, the report of the incidence of serious abnormal reaction around 0.1/10 million. 專家估計，我國近期不會出現大範圍的疫情暴發流行，但不排除在局部地區和人口集中場所(如學校等)出現小範 圍的聚集性疫情。
Experts estimate that China's recent large-scale epidemic does not appear outbreak, but did not rule out the population is concentrated in local areas and places (such as schools, etc.) appear in clusters of small-scale outbreaks. 考慮我國人群中甲型H1N1流感有效的免疫保護屏障尚未形成，現有的防控措施不能鬆懈，同時要高度關注季節 性流感和人感染高致病性禽流感的預防控制。
Take into account our population Influenza A H1N1 influenza effective immune protection barrier has not yet formed, the existing prevention and control measures can not be relaxed at the same time a high degree of attention to seasonal influenza and human infection with highly pathogenic avian influenza prevention and control.